Fifteen-year follow-up from the S0016 trial found over one-third of patients with follicular lymphoma treated with chemoimmunotherapy had no progression.
Dr. Jonathan W. Friedberg
Advertisement
Director of the Wilmot Cancer Institute at the University of Rochester Medical Center.
Articles by Dr. Jonathan W. Friedberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
4
If I Have Cancer Again
5